.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Symposien

Symposium 15
Repurposing of established drugs to treat cardiac arrhythmias

Appointment

Date: 09/03/2023

Time: 14:00 – 15:30

Location / Stream:

Chair

Programme

14:00 – 14:22 18 Min. 4 Min.
Online Lecture
Mesalazin as a lead compound to prevent structural remodeling in atrial fibrillation.
Stephan Künzel (Dresden / DE)
14:22 – 14:44 18 Min. 4 Min.
Lecture
Treatment of atrial fibrillation with doxapram
Constanze Schmidt (Heidelberg / DE)
14:44 – 15:06 18 Min. 4 Min.
Lecture
Ezitimibe: More than a lipid lowering drug.
Johann Schredelseker (München / DE)
15:06 – 15:28 18 Min. 4 Min.
Lecture
High-throughput screening approaches to identify novel antiarrhythmic compounds.
Niels Voigt (Göttingen / DE)

Symposium 15Repurposing of established drugs to treat cardiac arrhythmias

Appointment

Chair

Programme

Symposium 15
Repurposing of established drugs to treat cardiac arrhythmias